Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 7Z9Q | P10104 | CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex | |
| 7Z9R | P10104 | CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation | |
| 8BON | P10104 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
| 8R1C | P10104 | SD1-2 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | |
| 8R1D | P10104 | SD1-3 Fab in complex with SARS-CoV-2 BA.2.12.1 Spike Glycoprotein | |
| 4BLD | P10071 | Crystal structure of a human Suppressor of fused (SUFU)-GLI3p complex | |
| 7ALK | P10041 | Structure of Drosophila C2-DSL-EGF1 | |
| 8T4Z | P0DTU4 | T-cell receptor and lipid complex structure | |
| 8XS3 | P0DTN2 | Structure of MPXV B6 and D68 fab complex | |
| 6W4H | P0DTD1 | 1.80 Angstrom Resolution Crystal Structure of NSP16 - NSP10 Complex from SARS-CoV-2 | |
| 7L6R | P0DTD1 | Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and Manganese (Mn). | |
| 7L6T | P0DTD1 | Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and two Magnesium (Mg) ions. | |
| 7MPB | P0DTD1 | SARS Coronavirus-2 Main Protease 3CL-pro binding Ascorbate | |
| 7XMN | P0DTC8 | Structure of SARS-CoV-2 ORF8 | |
| 6XEY | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4 | SARS-CoV-2 spike glycoprotein, 2-4 Heavy Chain, 2-4 Light Chain |
| 6ZOW | P0DTC2 | SARS-CoV-2 spike in prefusion state | |
| 6ZOX | P0DTC2 | Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x2 disulphide-bond mutant, G413C, V987C, single Arg S1/S2 cleavage site) | Matrix protein 1 |
| 7A25 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) | Spike glycoprotein, Sybody 23 |
| 7A4N | P0DTC2 | Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer) | Spike glycoprotein,Fibritin |
| 7BH9 | P0DTC2 | SARS-CoV-2 RBD-62 in complex with ACE2 peptidase domain | |
| 7C01 | P0DTC2 | Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD | |
| 7CAK | P0DTC2 | SARS-CoV-2 S trimer with three RBD in the open state and complexed with three H014 Fab | Spike glycoprotein, Light chain of H014 Fab, Heavy chain of H014 Fab |
| 7D0C | P0DTC2 | S protein of SARS-CoV-2 in complex bound with P5A-3A1 | Spike glycoprotein, Light chain of Fab207, Heavy chain of Fab207 |
| 7DET | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DEU | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with a neutralizing antibody scFv | |
| 7DX0 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
| 7E3B | P0DTC2 | SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD) | |
| 7E5O | P0DTC2 | Crystal structure of SARS-CoV-2 RBD in complex with antibody NT-193 | |
| 7FDG | P0DTC2 | SARS-COV-2 Spike RBDMACSp6 binding to hACE2 | |
| 7FDK | P0DTC2 | SARS-COV-2 Spike RBDMACSp36 binding to mACE2 | |
| 7KJ2 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with one ACE2 Bound | Spike glycoprotein |
| 7KKK | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6 | SARS-CoV-2 spike glycoprotein, Synthetic nanobody Nb6 |
| 7KLH | P0DTC2 | SARS-CoV-2 RBD in complex with Fab 15033-7 | |
| 7KM5 | P0DTC2 | Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1 | |
| 7LD1 | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with Receptor Binding Domain antibody DH1047 | |
| 7LDJ | P0DTC2 | SARS-CoV-2 receptor binding domain in complex with WNb-2 | |
| 7LWI | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation | |
| 7M7B | P0DTC2 | SARS-CoV-2 Spike:Fab 3D11 complex focused refinement | Spike glycoprotein, Antibody Fab 3D11 heavy chain, Antibody Fab 3D11 light chain |
| 7MJK | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to Fab ab1 (class 2) | Spike glycoprotein, Fab ab1 Heavy Chain, Fab ab1 Light Chain |
| 7N0H | P0DTC2 | CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45) | |
| 7N1Q | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1T | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1U | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1V | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1W | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1X | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N1Y | P0DTC2 | Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants | |
| 7N3I | P0DTC2 | Crystal structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment C098 | |
| 7N62 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction) | |
| 7N64 | P0DTC2 | SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction) |
